Organisation: Crohn

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

general

Bowel disease can affect one in five people

What springs to mind when you hear the words inflammatory bowel disease or IBD? Dodgy bellies, toilet troubles?

news

Proof of illness may be sought to cut water bill

news

Maynooth researchers claim Crohn's disease breakthrough

news

Researchers make breakthrough in fight against Crohn’s disease

business

Elan reveals first quarter results

business

Elan reports revenue increase

Elan sees losses double in Q3

Pharmaceutical company Elan has seen its losses almost double to $117m (€93m) from $67m (€53m) in the three months to end of September, when compared with the same period last year.

Wed, 25 Oct, 2006

Elan: Tysabri suitable for treatment of Crohn's

ISEQ-listed drug company Elan says that its Tysabri drug, which was taken off the market for a time in 2004, is effective in maintaining remission in Crohn’s Disease patients treated for longer than two years.

Tue, 24 Oct, 2006

Elan shares fall as drug fails test

Shares in Elan fell yesterday when, together with US company Biogen, it announced that the Drug Antegren, failed an important clinical trail.

Fri, 25 Jul, 2003